These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 7863883)

  • 21. Cavernous hemangiomas of the liver. Association of sonographic appearance and results of Tc-99m labeled red blood cell SPECT.
    Jacobson AF; Teefey SA
    Clin Nucl Med; 1994 Feb; 19(2):96-9. PubMed ID: 8187411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of contrast enhancement of benign and malignant hepatic neoplasms during bolus dynamic and delayed CT.
    Freeny PC; Marks WM
    Radiology; 1986 Sep; 160(3):613-8. PubMed ID: 3016794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computer tomography imaging findings of adrenal cavernous hemangiomas: a report of 10 cases.
    Peng JP; Lv XF; Lin CL; Zhou J; Zhang YM; Zhang YH; Zhang XL
    Acta Radiol; 2016 Jan; 57(1):115-21. PubMed ID: 25585847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound (US) and computed tomographic (CT) appearances of large (giant) hepatic cavernous hemangiomas.
    Samad SA; Maimunah A; Zulfiqar A; Zaharah M
    Med J Malaysia; 1995 Mar; 50(1):82-6. PubMed ID: 7752982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computed tomography of hepatic haemangiomas: a chance for a definite diagnosis.
    Päivänsalo M; Lähde S; Jalovaara P
    Bildgebung; 1991; 58(1):29-32. PubMed ID: 2070098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Shiratori Y; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2010 Oct; 195(4):941-6. PubMed ID: 20858822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.
    Soyer P; Dufresne AC; Somveille E; Scherrer A
    AJR Am J Roentgenol; 1997 Feb; 168(2):461-5. PubMed ID: 9016227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computed tomography of cavernous hemangioma of the liver.
    Itai Y; Furui S; Araki T; Yashiro N; Tasaka A
    Radiology; 1980 Oct; 137(1 Pt 1):149-55. PubMed ID: 7422836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features?
    Gulpinar B; Peker E; Kul M; Elhan AH; Haliloglu N
    Abdom Radiol (NY); 2019 Jun; 44(6):2147-2155. PubMed ID: 30863999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast enhancement of hepatic hemangiomas on multiphase MDCT: Can we diagnose hepatic hemangiomas by comparing enhancement with blood pool?
    Oto A; Kulkarni K; Nishikawa R; Baron RL
    AJR Am J Roentgenol; 2010 Aug; 195(2):381-6. PubMed ID: 20651193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Well-defined, dense and continuously spreading enhancement on single level dynamic CT of the liver: a characteristic sign of hepatic cavernous haemangioma.
    Itai Y; Araki T; Ohtomo K; Kokubo T; Yoshida H; Minami M; Yashiro N
    Rofo; 1989 Dec; 151(6):697-701. PubMed ID: 2556746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization.
    Stark DD; Felder RC; Wittenberg J; Saini S; Butch RJ; White ME; Edelman RR; Mueller PR; Simeone JF; Cohen AM
    AJR Am J Roentgenol; 1985 Aug; 145(2):213-22. PubMed ID: 2992250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US.
    Isozaki T; Numata K; Kiba T; Hara K; Morimoto M; Sakaguchi T; Sekihara H; Kubota T; Shimada H; Morizane T; Tanaka K
    Radiology; 2003 Dec; 229(3):798-805. PubMed ID: 14563903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Giant cavernous hemangioma of the liver: atypical CT and MR findings.
    Valls C; Reñe M; Gil M; Sanchez A; Narvaez JA; Hidalgo F
    Eur Radiol; 1996; 6(4):448-50. PubMed ID: 8798020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of Hepatic Sclerosed Hemangiomas From Cavernous Hemangiomas Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features.
    Hwang JA; Kang TW; Cha DI; Kim SH; Ha SY; Kim SW
    J Comput Assist Tomogr; 2019; 43(5):762-769. PubMed ID: 31356526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemangioma in the cirrhotic liver: diagnosis and natural history.
    Brancatelli G; Federle MP; Blachar A; Grazioli L
    Radiology; 2001 Apr; 219(1):69-74. PubMed ID: 11274536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The radiology of cavernous hemangioma of the liver.
    Lipman JC; Tumeh SS
    Crit Rev Diagn Imaging; 1990; 30(1):1-18. PubMed ID: 2405879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings.
    Mastropasqua M; Kanematsu M; Leonardou P; Braga L; Woosley JT; Semelka RC
    Magn Reson Imaging; 2004 Jan; 22(1):15-8. PubMed ID: 14972389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic cavernous hemangiomas: lack of enlargement over time.
    Mungovan JA; Cronan JJ; Vacarro J
    Radiology; 1994 Apr; 191(1):111-3. PubMed ID: 8134554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed tomography and magnetic resonance imaging findings of nasal cavity hemangiomas according to histological type.
    Kim JH; Park SW; Kim SC; Lim MK; Jang TY; Kim YJ; Kang YH; Lee HY
    Korean J Radiol; 2015; 16(3):566-74. PubMed ID: 25995686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.